Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice

Journal of Ethnopharmacology

Volumn 176, Issue , 2015, Pages 17-26

  Jiang, Cuihua ^a,b   Wang, Qingqing ^a,b   Wei, YuJian ^c   Yao, Nan ^a   Wu, Zhengfeng ^a,b   Ma, Yonglan ^a,b   Lin, Zi ^a,b   Zhao, Ming ^d   Che, Chuntao ^d   Yao, Xiaoming ^e   Zhang, Jian ^a   Yin, Zhiqi ^b  

^a Jiangsu Province Academy of Traditional Chinese Medicine   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acyl CoA cholesterol acyltransferase 2 (ACAT2); Cholesterol 7 hydroxylase (CYP7A1); Cyclocarya paliurus; HMG CoA reductase; Hyperlipidemia

Indexed keywords

3BETA 23 DIHYREOXY 12 ENE 28 URSOLIC ACID; ACYL COA CHOLESTEROL ACYLTRANSFERASE 2; ALANINE AMINOTRANSFERASE; ARJUNOLIC ACID; ASPARTATE AMINOTRANSFERASE; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; CREATININE; CYCLOCARIC ACID B; FAT DROPLET; HEDERAGENIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MYCLOCARYA PALIURUS EXTRACT; NITROGEN; OLEANOLIC ACID; OLEIC ACID; PLANT EXTRACT; PTEROCARYOSIDE B; SIMVASTATIN; TRIACYLGLYCEROL; TRITERPENOID; UNCLASSIFIED DRUG; UREA; URIC ACID; ANTILIPEMIC AGENT; CYP7A1 PROTEIN, MOUSE; STEROL O-ACYLTRANSFERASE 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYCLOCARYA PALIURUS; ENZYME ACTIVITY; FOOD INTAKE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERLIPIDEMIA; IN VITRO STUDY; JUGLANDACEAE; LIPID DIET; LIPID STORAGE; LIQUID CHROMATOGRAPHY; LIVER WEIGHT; MALE; MASS SPECTROMETRY; MICROSCOPY; MOUSE; NONHUMAN; OBESITY; PHYTOCHEMISTRY; PLANT LEAF; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; DRUG EFFECTS; FECES; GENETICS; HUMAN; HYPERLIPIDEMIAS; LIVER; METABOLISM; PATHOLOGY; PHYTOTHERAPY;

ANIMALS; BILE ACIDS AND SALTS; CELL LINE; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET, HIGH-FAT; FECES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; JUGLANDACEAE; LIVER; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; STEROL O-ACYLTRANSFERASE; TRIGLYCERIDES;

EID: 84945896764     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.10.006     Document Type: Article

References (48)

1. B.J. Arsenault, J.S. Rana, E.S. Stroes, J.-P. Després, P.K. Shah, J.J. Kastelein, N.J. Wareham, S.M. Boekholdt, and K.-T. Khaw Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women J. Am. Coll. Cardiol. 55 2009 35 41
2. J.L. Beaumont, L.A. Carlson, G.R. Cooper, Z. Fejfar, D.S. Fredrickson, and T. Strasser Classification of hyperlipidemias and hyperlipoproteinemias Bull. WHO 43 1970 891
3. J.D. Berry, A. Dyer, X. Cai, D.B. Garside, H. Ning, A. Thomas, P. Greenland, L. Van Horn, R.P. Tracy, and D.M. Lloyd-Jones Lifetime risks of cardiovascular disease New. Engl. J. Med. 366 2012 321 329
4. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
5. M.S. Butt, N. Shahzadi, M.K. Sharif, and M. Nasir Guar gum: a miracle therapy for hypercholesterolemia, hyperglycemia and obesity Crit. Rev. Food Sci. Nutr. 47 2007 389 396
6. A. Canbay, L. Bechmann, and G. Gerken Lipid metabolism in the liver Z. Gastroenterol. 45 2007 35 41
7. J. Chiang, R. Kimmel, and D. Stroup Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha) Gene 262 2001 257
8. J. de Lemos, E. Braunwald, M. Blazing, S. Murphy, J. Downs, A. Gotto, M. Clearfield, H. Holdaas, D. Gordon, and B. Davis Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
9. G. Derosa, S. Salvadeo, and A. Cicero Prospects for the development of novel anti-hyperlipidemic drugs Curr. Opin. Investig. Drugs 7 2006 826 833
10. J.M. Dietschy, D.K. Spady, and E.F. Stange Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation Biochem. Soc. Trans. 11 1983 639 641
11. F.U. Xiangxiang Secondary metabolites and its physiological function of Cyclocarya paliurus J. Anhui Agric. Sci. 28 2009 072
12. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J. Clin. Investig. 52 1973 1544 1568
13. P. Guo, Q. Kai, J. Gao, Z.Q. Lian, C.M. Wu, C.A. Wu, and H.B. Zhu Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase J. Pharmacol. Sci. 113 2010 395 403
14. L. Han, P. Lai, and J.-R. Du Deciphering molecular mechanism underlying hypolipidemic activity of echinocystic acid Evidence-Based Complement. Altern. Med. 2014 2014
15. K. Harchaoui, M. Visser, J. Kastelein, E. Stroes, and G. Dallinga-Thie Triglycerides and cardiovascular risk Curr. Cardiol. Rev. 5 2009 216
16. V. Hirunpanich, A. Utaipat, N.P. Morales, N. Bunyapraphatsara, H. Sato, A. Herunsale, and C. Suthisisang Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats J. Ethnopharmacol. 103 2006 252 260
17. M.Q. Huang, X.C. Shangguan, M.S. Xu, W.J. Wang, Y.G. Shen, Y. Jiang, Q. Chen, and T.T. Chen Studies on hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja polysaccharide Acta Agric. Univ. Jiangxiensis 33 2011 157 161
18. E.S. Istvan, and J. Deisenhofer Structural mechanism for statin inhibition of HMG-CoA reductase Science 292 2001 1160 1164
19. K.S. Jain, M.K. Kathiravan, R.S. Somani, and C.J. Shishoo The biology and chemistry of hyperlipidemia Bioorganic Med. Chem. 15 2007 4674 4699
20. H. Jurevics, J. Hostettler, C. Barrett, P. Morell, and A.D. Toews Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase J. Lipid Res. 41 2000 1048 1053
21. D.-H. Kim, K.-M. Han, I.-S. Chung, D.-K. Kim, S.-H. Kim, B.-M. Kwon, T.-S. Jeong, M.-H. Park, E.-M. Ahn, and N.-I. Baek Triterpenoids from the flower of Campsis grandiflora K. Schum. as human acyl-CoA: cholesterol acyltransferase inhibitors Arch. Pharmacol. Res. 28 2005 550 556
22. H. Kurihara, S. Asami, H. Shibata, H. Fukami, and T. Tanaka Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice Biol. Pharm. Bull. 26 2003 383 385
23. M.-K. Lee, S.-S. Moon, S.-E. Lee, S.-H. Bok, T.-S. Jeong, Y.B. Park, and M.-S. Choi Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats Bioorganic Med. Chem. 11 2003 393 398
24. R. Leng Fundamental research and clinical observations of Cyclocarya paliurus Jiangxi Univ. Tradit. Chin. Med. 25 1994 64 65
25. M.C. Lewis, L.E. Brieaddy, and C. Root Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice J. Lipid Res. 36 1995 1098 1105
26. S.J. Lewis Lipid-lowering therapy: who can benefit? Vasc. Health Risk Manag. 7 2011 525 534
27. H. Li, Q.J. Wang, D.N. Zhu, and Y. Yang Reinioside C, a triterpene saponin of Polygala aureocauda Dunn, exerts hypolipidemic effect on hyperlipidemic mice Phytother. Res. 22 2008 159 164
28. S. Li, J. Li, X.L. Guan, J. Li, S.P. Deng, L.Q. Li, M.T. Tang, J.G. Huang, Z.Z. Chen, and R.Y. Yang Hypoglycemic effects and constituents of the barks of Cyclocarya paliurus and their inhibiting activities to glucosidase and glycogen phosphorylase Fitoterapia 82 2011 1081 1085
29. H. Lu, J. Chen, W.L. Li, B.R. Ren, J.L. Wu, H.Y. Kang, H.Q. Zhang, A. Adams, and N. De Kimpe Hypoglycemic and hypolipidemic effects of the total triterpene acid fraction from Folium Eriobotryae J. Ethnopharmacol. 122 2009 486 491
30. Y. Ma, W. Wang, J. Zhang, Y. Lu, W. Wu, H. Yan, and Y. Wang Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet Plos One 7 2012 e35835
31. X. Pang, M. Yao, Y. Lu, and Q. Gong Effect of soy isoflavones on malondialdehyde and superoxide dismutase of blood and liver in hypercholesterolemia rats Chin. J. New Drugs Clin. Remedies 21 2002 257 261
32. C.R. Pullinger, C. Eng, G. Salen, S. Shefer, A.K. Batta, S.K. Erickson, A. Verhagen, C.R. Rivera, S.J. Mulvihill, and M.J. Malloy Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype J. Clin. Investig. 110 2002 109 117
33. F.A. Santos, J.T. Frota, B.R. Arruda, T.S. de Melo, A. da Silva, G. Brito, M.H. Chaves, and V.S. Rao Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice Lipids Health Dis. 11 2012 98
34. M.Q. Shen, J.Y. Liang, Z.H. Jiao, Y.H. Guo, G.Z. Meng, X.Q. Shen, F. Li, R.S. Zhang, L. Chen, and G.B. Xiao Clinical observation on regulation action of Green Qian Willow tea on blood lipid level Pract. J. Chin. West. Med. 2 2002 863 865
35. R.G. Shu, C.R. Xu, L.N. Li, and Z.L. Yu Cyclocariosides II and III: two secodammarane triterpenoid saponins from Cyclocarya paliurus planta Med. 61 1995 551 553
36. L. Somova, A. Nadar, P. Rammanan, and F. Shode Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension Phytomedicine: Int. J. Phytother. Phytopharm. 10 2003 115 121
37. O. Stein, and Y. Stein Atheroprotective mechanism of HDL Atherosclerosis 144 1999 285 301
38. D. Steinberg The statins in preventive cardiology New Engl. J. Med. 359 2008 1426 1427
39. K.E. Suckling, and E.F. Stange Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism J. Lipid Res. 26 1985 647 671
40. P.P. Toth Drug treatment of hyperlipidaemia Drugs 70 2010 1363 1379
41. N.L. Urizar, and D.D. Moore GUGULIPID: a natural cholesterol-lowering agent Annu. Rev. Nutr. 23 2003 303 313
42. K. Wang, and Y. Cao Research progress in the chemical constituents and pharmacologic activities of Cyclocarya Paliurus (Batal.) Iljinshaja Hei Long. Jiang Med. J. 31 2007 577 579
43. Q. Wang, C. Jiang, S. Fang, J. Wang, Y. Ji, X. Shang, Y. Ni, Z. Yin, and J. Zhang Antihyperglycemic, antihyperlipidemic and antioxidant effects of ethanol and aqueous extracts of Cyclocarya paliurus leaves in type 2 diabetic rats J. Ethnopharmacol. 150 2013 1119 1127
44. X. Wang, R. Liu, W. Zhang, X. Zhang, N. Liao, Z. Wang, W. Li, X. Qin, and C. Hai Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects Mol. Cell. Endocrinol. 376 2013 70 80
45. Y. Wang, Z. Wang, H. Shen, M. Yin, and K. Tang Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit Eur. J. Pharm. Sci. 50 2013 366 371
46. A.S. Wierzbicki, T.C. Hardman, and A. Viljoen New lipid-lowering drugs: an update Int. J. Clin. Pract. 66 2012 270 280
47. M. Xie, and J. Xie Review about the research on Cyclocarya paliurus (Batal.) Iljinskaja J. Food Sci. Biotechnol. 27 2008 113 121
48. M.Y. Xie, and L. Li Review in studies on chemical constituents and bioactivities of Cyclocarya paliurus Chin. Tradit. Herb. Drugs 32 2001 365 366